1
|
Rodríguez MCR, Chen-Zhao X, Hernando O, Flamarique S, Fernández-Letón P, Campo M, López M, Rodríguez M, Zucca D, Martínez D, Sánchez-Saugar E, Mañeru F, Ruiz-Zorrilla JG, de Acilu PG, Valero J, Montero A, Ciérvide R, Alvarez B, García-Aranda M, Alonso R, de la Casa MA, Alonso L, Nuñez M, Martí J, Arias F. SBRT-SG-01: final results of a prospective multicenter study on stereotactic body radiotherapy for liver metastases. Clin Transl Oncol 2024:10.1007/s12094-024-03403-w. [PMID: 38431539 DOI: 10.1007/s12094-024-03403-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Accepted: 02/01/2024] [Indexed: 03/05/2024]
Abstract
OBJECTIVE This study aimed to assess the efficacy and tolerability of stereotactic body radiation therapy (SBRT) for the treatment of liver metastases. METHODS Patients with up to 5 liver metastases were enrolled in this prospective multicenter study and underwent SBRT. Efficacy outcomes included in-field local control (LC), progression-free survival (PFS), and overall survival (OS). Acute and late toxicities were evaluated using CTCAE v.4.0. RESULTS A total of 52 patients with 105 liver metastases were treated between 2015 and 2018. The most common primary tumor was colorectal cancer (72% of cases). Liver metastases were synchronous with the primary tumor diagnosis in 24 patients (46.2%), and 21 patients (40.4%) presented with other extrahepatic oligometastases. All patients underwent intensity-modulated radiation therapy (IMRT)/volumetric-modulated arc therapy (VMAT) with image-guided radiation therapy (IGRT) and respiratory gating, and a minimum biologically effective dose (BED10Gy) of 100 Gy was delivered to all lesions. With a median follow-up of 23.1 months (range: 13.4-30.9 months) since liver SBRT, the median actuarial local progression-free survival (local-PFS) was not reached. The actuarial in-field LC rates were 84.9% and 78.4% at 24 and 48 months, respectively. The median actuarial liver-PFS and distant-PFS were 11 and 10.8 months, respectively. The actuarial median overall survival (OS) was 27.7 months from SBRT and 52.5 months from metastases diagnosis. Patients with lesion diameter ≤ 5 cm had significantly better median liver-PFS (p = 0.006) and OS (p = 0.018). No acute or late toxicities of grade ≥ 3 were observed. CONCLUSIONS This prospective multicenter study confirms that liver SBRT is an effective alternative for the treatment of liver metastases, demonstrating high rates of local control and survival while maintaining a low toxicity profile.
Collapse
Affiliation(s)
| | - Xin Chen-Zhao
- Radiation Oncology, Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain
| | - Ovidio Hernando
- Radiation Oncology, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain
| | - Sonia Flamarique
- Radiation Oncology, Complejo Hospitalario de Navarra, Navarra, Spain
| | - Pedro Fernández-Letón
- Medical Physics, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain
| | - Maider Campo
- Radiation Oncology, Complejo Hospitalario de Navarra, Navarra, Spain
| | - Mercedes López
- Radiation Oncology, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain
| | - Maitane Rodríguez
- Radiation Oncology, Complejo Hospitalario de Navarra, Navarra, Spain
| | - Daniel Zucca
- Medical Physics, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain
| | - Daniel Martínez
- Medical Physics, Complejo Hospitalario de Navarra, Navarra, Spain
| | - Emilio Sánchez-Saugar
- Radiation Oncology, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain
| | - Fernando Mañeru
- Medical Physics, Complejo Hospitalario de Navarra, Navarra, Spain
| | | | - Paz García de Acilu
- Medical Physics, Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain
| | - Jeannette Valero
- Radiation Oncology, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain
| | - Angel Montero
- Radiation Oncology, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain
| | - Raquel Ciérvide
- Radiation Oncology, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain
| | - Beatriz Alvarez
- Radiation Oncology, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain
| | - Mariola García-Aranda
- Radiation Oncology, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain
| | - Rosa Alonso
- Radiation Oncology, Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain
| | | | - Leyre Alonso
- Medical Physics, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain
| | - Mónica Nuñez
- Radiation Oncology, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain
| | - Jaime Martí
- Medical Physics, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain
| | - Fernando Arias
- Radiation Oncology, Complejo Hospitalario de Navarra, Navarra, Spain
| |
Collapse
|
2
|
Trilla-Fuertes L, Gámez-Pozo A, Nogué M, Busquier I, Arias F, López-Campos F, Fernández-Montes A, Ruiz A, Velázquez C, Martín-Bravo C, Pérez-Ruiz E, Asensio E, Hernández-Yagüe X, Rodrigues A, Ghanem I, López-Vacas R, Hafez A, Arias P, Dapía I, Solís M, Dittmann A, Ramos R, Llorens C, Maurel J, Campos-Barros Á, Fresno Vara JÁ, Feliu J. Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma. Cancer 2023. [PMID: 37096763 DOI: 10.1002/cncr.34797] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Revised: 03/01/2023] [Accepted: 03/03/2023] [Indexed: 04/26/2023]
Abstract
BACKGROUND Anal squamous cell carcinoma (ASCC) is an infrequent tumor whose treatment has not changed since the 1970s. The aim of this study is the identification of biomarkers allowing personalized treatments and improvement of therapeutic outcomes. METHODS Forty-six paraffin tumor samples from ASCC patients were analyzed by whole-exome sequencing. Copy number variants (CNVs) were identified and their relation to disease-free survival (DFS) was studied and validated in an independent retrospective cohort of 101 ASCC patients from the Multidisciplinary Spanish Digestive Cancer Group (GEMCAD). GEMCAD cohort proteomics allowed assessing the biological features of these tumors. RESULTS On the discovery cohort, the median age was 61 years old, 50% were males, stages I/II/III: 3 (7%)/16 (35%)/27 (58%), respectively, median DFS was 33 months, and overall survival was 45 months. Twenty-nine genes whose duplication was related to DFS were identified. The most representative was duplications of the CYP2D locus, including CYP2D6, CYP2D7P, and CYP2D8P genes. Patients with CYP2D6 CNV had worse DFS at 5 years than those with two CYP2D6 copies (21% vs. 84%; p < .0002, hazard ratio [HR], 5.8; 95% confidence interval [CI], 2.7-24.9). In the GEMCAD validation cohort, patients with CYP2D6 CNV also had worse DFS at 5 years (56% vs. 87%; p = .02, HR = 3.6; 95% CI, 1.1-5.7). Mitochondria and mitochondrial cell-cycle proteins were overexpressed in patients with CYP2D6 CNV. CONCLUSIONS Tumor CYP2D6 CNV identified patients with a significantly worse DFS at 5 years among localized ASCC patients treated with 5-fluorouracil, mitomycin C, and radiotherapy. Proteomics pointed out mitochondria and mitochondrial cell-cycle genes as possible therapeutic targets for these high-risk patients. PLAIN LANGUAGE SUMMARY Anal squamous cell carcinoma is an infrequent tumor whose treatment has not been changed since the 1970s. However, disease-free survival in late staged tumors is between 40% and 70%. The presence of an alteration in the number of copies of CYP2D6 gene is a biomarker of worse disease-free survival. The analysis of the proteins in these high-risk patients pointed out mitochondria and mitochondrial cell-cycle genes as possible therapeutic targets. Therefore, the determination of the number of copies of CYP2D6 allows the identification of anal squamous carcinoma patients with a high-risk of relapse that could be redirected to a clinical trial. Additionally, this study may be useful to suggest new treatment strategies to increase current therapy efficacy.
Collapse
Affiliation(s)
| | - Angelo Gámez-Pozo
- Molecular Oncology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain
- Biomedica Molecular Medicine SL, Madrid, Spain
| | - Miguel Nogué
- Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain
- Medical Oncology Service, Hospital de Granollers, Barcelona, Spain
| | - Isabel Busquier
- Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain
- Medical Oncology Service, Hospital Provincial de Castellón, Castellón, Spain
| | - Fernando Arias
- Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain
- Radiotherapy Oncology Service, Complejo Hospitalario de Navarra, Navarra, Spain
| | - Fernando López-Campos
- Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain
- Radiotherapy Oncology Service, Hospital Ramón y Cajal, Madrid, Spain
| | - Ana Fernández-Montes
- Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain
- Medical Oncology Service, Complejo Hospitalario Universitario de Ourense, Ourense, Spain
| | - Ana Ruiz
- Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain
- Medical Oncology Service, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain
| | - Concepción Velázquez
- Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain
- Medical Oncology Service, Hospital Miguel Servet, Zaragoza, Spain
| | | | - Elisabeth Pérez-Ruiz
- Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga, Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
| | - Elena Asensio
- Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain
- Medical Oncology Service, Hospital General Universitario de Elche, Elche, Spain
| | - Xavier Hernández-Yagüe
- Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain
- Medical Oncology Service, Instituto Catalán de Oncología-Girona, Girona, Spain
| | - Aline Rodrigues
- Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain
- Medical Oncology Service, Hospital Universitario de Salamanca, Salamanca, Spain
| | - Ismael Ghanem
- Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain
- Medical Oncology Service, Hospital Universitario La Paz, Madrid, Spain
| | - Rocío López-Vacas
- Molecular Oncology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain
| | - Ahmed Hafez
- Biotechvana SL, Parque Científico de Madrid, Madrid, Spain
| | - Pedro Arias
- Pharmacogenetics Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, Madrid, Spain
| | - Irene Dapía
- Pharmacogenetics Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, Madrid, Spain
| | - Mario Solís
- Bioinformatics Unit, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain
| | - Antje Dittmann
- Functional Genomics Center Zurich, University of Zurich/ETH Zurich, Zurich, Switzerland
| | - Ricardo Ramos
- Genomics Unit, Parque Científico de Madrid, Madrid, Spain
| | - Carlos Llorens
- Biotechvana SL, Parque Científico de Madrid, Madrid, Spain
| | - Joan Maurel
- Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain
- Medical Oncology Department, Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, IDIBAPS, University of Barcelona, Barcelona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
| | - Ángel Campos-Barros
- Institute of Medical and Molecular Genetics, IdiPAZ, Hospital Universitario La Paz/CIBERER Unit 753, ISCIII, Madrid, Spain
| | - Juan Ángel Fresno Vara
- Molecular Oncology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain
- Biomedica Molecular Medicine SL, Madrid, Spain
- Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain
| | - Jaime Feliu
- Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain
- Medical Oncology Service, Hospital Universitario La Paz, Madrid, Spain
- Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain
- Cátedra UAM-Amgen, Universidad Autónoma de Madrid, Madrid, Spain
| |
Collapse
|
3
|
Ubeda C, Vano E, Perez MD, Jímenez P, Ramirez R, Nader A, Miranda P, Azcurra P, Damsky J, Capdevila S, Oliveira M, Albuquerque J, Bocamino R, Schelin H, Yagui A, Aguirre D, Riquelme N, Cardenas L, Álvarez A, Mosquera W, Arias F, Gutierrez R, De la Mora R, Rivera T, Zapata J, Araujo P, Chiesa P. Setting up regional diagnostic reference levels for pediatric interventional cardiology in Latin America and the Caribbean countries: preliminary results and identified challenges. J Radiol Prot 2022; 42:031513. [PMID: 35940166 DOI: 10.1088/1361-6498/ac87b7] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/30/2022] [Accepted: 08/08/2022] [Indexed: 06/15/2023]
Abstract
The goal of the present study was to propose a set of preliminary regional diagnostic reference levels (DRLs) for pediatric interventional cardiology (IC) procedures in Latin America and the Caribbean countries, classified by age and weight groups. The study was conducted in the framework of the Optimization of Protection in Pediatric Interventional Radiology in Latin America and the Caribbean program coordinated by the World Health Organization and the Pan American Health Organization in cooperation with the International Atomic Energy Agency. The first step of the program was focused on pediatric IC. Dose data from diagnostic and therapeutic procedures were collected between December 2020 and December 2021. Regional DRLs were set as the third quartile of patient dose data (kerma area product) collected in 18 hospitals from 10 countries in an initial sample of 968 procedures. DRLs were set for four age bands and five weight ranges. The values obtained for the four age bands (<1 yr, 1 to <5 yr, 5 to <10 yr and 10 to <16 yr) were 2.9, 6.1, 8.8 and 14.4 Gy cm2for diagnostic procedures, and 4.0, 5.0, 10.0 and 38.1 Gy cm2for therapeutic procedures, respectively. The values obtained for the five weight bands (<5 kg, 5 to <15 kg, 15 to <30 kg, 30 to <50 kg and 50 to <80 kg) were 3.0, 4.5, 8.1, 9.2 and 26.8 Gy cm2for diagnostic procedures and 3.7, 4,3, 7.3, 16.1 and 53.4 Gy cm2for therapeutic procedures, respectively. While initial data were collected manually as patient dose management systems (DMSs) were not available in most of the hospitals involved in the program, a centralized automatic DMS for the collection and management of patient dose indicators has now been introduced and is envisaged to increase the sample size. The possibility of alerting on high dose values and introducing corrective actions will help in optimization.
Collapse
Affiliation(s)
- C Ubeda
- Departamento de Tecnología Médica, Facultad de Ciencias de la Salud, Universidad de Tarapacá, Arica, Chile
| | - E Vano
- Radiology Department, Faculty of Medicine, Complutense University and IdIS, San Carlos Hospital, 28040 Madrid, Spain
| | - M D Perez
- World Health Organization (WHO), Geneva, Switzerland
| | - P Jímenez
- Pan American Health Organization (PAHO), Washington, DC, United States of America
| | - R Ramirez
- International Atomic Energy Agency (IAEA), Vienna, Austria
| | - A Nader
- International Atomic Energy Agency (IAEA), Vienna, Austria
| | - P Miranda
- Luis Calvo Mackenna's Hospital, AntonioVaras 360, Santiago, Chile
| | - P Azcurra
- Hemodynamic Service, Italian Hospital, Buenos Aires, Argentina
| | - J Damsky
- Hemodynamic Service, Pedro de Elizalde Children's Hospital, Buenos Aires, Argentina
| | - S Capdevila
- Hemodynamic Service, Santísima Trinidad Children's Hospital, Córdova, Argentina
| | - M Oliveira
- Department of Health Technology and Biology, Federal Institute of Bahia, Salvador, Brazil
| | - J Albuquerque
- University Hospital of the Federal University of Maranhão, San Luis, Brasil
| | - R Bocamino
- Clinical Hospital of the Federal University of Paraná, Curitiba, Brasil
| | - H Schelin
- Pequeno Príncipe Hospital, Curitiba, Brasil
| | - A Yagui
- Pequeno Príncipe Hospital, Curitiba, Brasil
| | - D Aguirre
- Hemodynamic Service, Roberto del Rio Children's, Santiago, Chile
| | - N Riquelme
- Hemodynamic Service, Roberto del Rio Children's, Santiago, Chile
| | - L Cardenas
- Hemodynamic Service, Santa Maria Clinic, Santiago, Chile
| | - A Álvarez
- Hemodynamic Service, Santa Maria Clinic, Santiago, Chile
| | - W Mosquera
- Valle del Lili Foundation University Hospital ICESI, Cali, Colombia
| | - F Arias
- National Children's Hospital, San José, Costa Rica
| | - R Gutierrez
- National Children's Hospital, San José, Costa Rica
| | - R De la Mora
- National Directorate of Environmental Health, Ministry of Public Health, Havana, Cuba
| | - T Rivera
- Center for Research in Applied Sciences and Advanced Technology Legaria, IPN, Ciudad de México, Mexico
| | - J Zapata
- National Institute of Child Health St. Borja, Lima, Peru
| | - P Araujo
- National Cardiovascular Institute, Lima, Peru
| | - P Chiesa
- Children's Cardiology Institute, Montevideo, Uruguay
| |
Collapse
|
4
|
Arias F, Guerra-Adames A, Zambrano M, Quintero-Guerra E, Tejedor-Flores N. Analyzing Spanish-Language Public Sentiment in the Context of a Pandemic and Social Unrest: The Panama Case. Int J Environ Res Public Health 2022; 19:10328. [PMID: 36011965 PMCID: PMC9408347 DOI: 10.3390/ijerph191610328] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Revised: 08/14/2022] [Accepted: 08/16/2022] [Indexed: 06/15/2023]
Abstract
Over the past decade, an increase in global connectivity and social media users has changed the way in which opinions and sentiments are shared. Platforms such as Twitter can act as public forums for expressing opinions on non-personal matters, but often also as an outlet for individuals to share their feelings and personal thoughts. This becomes especially evident during times of crisis, such as a massive civil disorder or a pandemic. This study proposes the estimation and analysis of sentiments expressed by Twitter users of the Republic of Panama during the years 2019 and 2020. The proposed workflow is comprised of the extraction, quantification, processing and analysis of Spanish-language Twitter data based on Sentiment Analysis. This case of study highlights the importance of developing natural language processing resources explicitly devised for supporting opinion mining applications in Latin American countries, where language regionalisms can drastically change the lexicon on each country. A comparative analysis performed between popular machine learning algorithms demonstrated that a version of a distributed gradient boosting algorithm could infer sentiment polarity contained in Spanish text in an accurate and time-effective manner. This algorithm is the tool used to analyze over 20 million tweets produced between the years of 2019 and 2020 by residents of the Republic of Panama, accurately displaying strong sentiment responses to events occurred in the country over the two years that the analysis performed spanned. The obtained results highlight the potential that methodologies such as the one proposed in this study could have for transparent government monitoring of responses to public policies on a population scale.
Collapse
Affiliation(s)
- Fernando Arias
- Research Group on Advanced Technologies of Telecommunications and Signal Processing (GITTS), Faculty of Electrical Engineering, Technological University of Panama, Panama City 0819-07289, Panama
- Centro de Estudios Multidisciplinarios en Ciencias, Ingeniería y Tecnología AIP (CEMCIT-AIP), Technological University of Panama, Panama City 0819-07289, Panama
- Centro de Investigación e Innovación Eléctrica, Mecánica y de la Industria (CINEMI), Technological University of Panama, Panama City 0819-07289, Panama
| | - Ariel Guerra-Adames
- Research Group on Advanced Technologies of Telecommunications and Signal Processing (GITTS), Faculty of Electrical Engineering, Technological University of Panama, Panama City 0819-07289, Panama
- Centro de Estudios Multidisciplinarios en Ciencias, Ingeniería y Tecnología AIP (CEMCIT-AIP), Technological University of Panama, Panama City 0819-07289, Panama
| | - Maytee Zambrano
- Research Group on Advanced Technologies of Telecommunications and Signal Processing (GITTS), Faculty of Electrical Engineering, Technological University of Panama, Panama City 0819-07289, Panama
- Centro de Estudios Multidisciplinarios en Ciencias, Ingeniería y Tecnología AIP (CEMCIT-AIP), Technological University of Panama, Panama City 0819-07289, Panama
| | - Efraín Quintero-Guerra
- Research Group on Advanced Technologies of Telecommunications and Signal Processing (GITTS), Faculty of Electrical Engineering, Technological University of Panama, Panama City 0819-07289, Panama
| | - Nathalia Tejedor-Flores
- Centro de Estudios Multidisciplinarios en Ciencias, Ingeniería y Tecnología AIP (CEMCIT-AIP), Technological University of Panama, Panama City 0819-07289, Panama
- Centro de Investigaciones Hidráulicas e Hidrotécnicas (CIHH), Technological University of Panama, Panama City 0819-07289, Panama
| |
Collapse
|
5
|
Ibáñez P, Valladolid V, Villa-Abaunza A, Espinosa A, Arias F, Galve P, Sánchez-Parcerisa D, Udías J. PO-1730 Real-time hybrid Monte Carlo for dose calculation in proton therapy. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03694-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
6
|
Rubio Rodríguez M, Arias F, Chen-Zhao X, Flamarique S, Fernández-Letón P, Campo M, López M, Rodríguez M, Zucca D, Martínez D, Sánchez-Saugar E, Mañeru F, García Ruiz-Zorrilla J, García de Acilu P, Valero J, Montero A, Ciérvide R, Alvarez B, García-Aranda M, Alonso R, de la Casa M, Alonso L, Nuñez M, Martí J, Hernando O. OC-0416 Results of SBRT-SG-01, a prospective multicentric-study of SBRT for liver metastases. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)06903-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
7
|
Elfanagely O, Gorrai A, Wallden O, Arias F, Feingold DL, Patel NM. Understanding colorectal twitter: A comparison of its highest and lowest rank influencers. Cancer Treat Res Commun 2021; 28:100419. [PMID: 34147006 DOI: 10.1016/j.ctarc.2021.100419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2021] [Revised: 05/02/2021] [Accepted: 06/01/2021] [Indexed: 11/19/2022]
Abstract
The distribution of content related to colorectal surgery in social media is steadily increasing. Social media influencers possess large audiences and are frequently viewed as authority; however, their credibility is often unchecked. In our commentary we present our analysis and comparison of the most and least influential accounts on Twitter within the field of colorectal surgery. Additionally, we discuss the current literature, role and importance of social media for the modern surgeon.
Collapse
Affiliation(s)
- Omar Elfanagely
- Division of Colorectal Surgery, Department of Surgery, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America.
| | - Ananya Gorrai
- Department of Medical Education, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
| | - Olivia Wallden
- Department of Medical Education, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
| | - Fernando Arias
- Division of Colorectal Surgery, Department of Surgery, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
| | - Daniel L Feingold
- Division of Colorectal Surgery, Department of Surgery, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
| | - Nell Maloney Patel
- Division of Colorectal Surgery, Department of Surgery, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
| |
Collapse
|
8
|
Suárez J, Mata E, Guerra A, Jiménez G, Montes M, Arias F, Ciga MA, Ursúa E, Ederra M, Arín B, Laiglesia M, Sanz A, Vera R. Impact of the COVID-19 pandemic during Spain's state of emergency on the diagnosis of colorectal cancer. J Surg Oncol 2020; 123:32-36. [PMID: 33078425 DOI: 10.1002/jso.26263] [Citation(s) in RCA: 40] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2020] [Revised: 10/01/2020] [Accepted: 10/03/2020] [Indexed: 12/13/2022]
Abstract
INTRODUCTION We evaluate the impact of COVID-epidemic in colorectal cancer (CRC) diagnosis during Spain's state of emergency. METHODS We compared newly diagnosed patients with patients diagnosed in the same period of 2019. RESULTS A new diagnosis of CRC decreased 48% with a higher rate of patients diagnosed in the emergency setting (12.1% vs. 3.6%; p = .048) and a lower rate diagnosed in the screening program (5.2% vs. 33.3%; p = .000). CONCLUSIONS Fewer patients have been diagnosed with CRC, with a higher rate of patients diagnosed in an emergency setting.
Collapse
Affiliation(s)
- Javier Suárez
- Coloproctology Unit, Department of General Surgery, Complejo Hospitalario de Navarra, Pamplona, Spain.,Nurse Navigator, Colorectal Cancer Multidisciplinary Unit, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Elena Mata
- Department of Medical Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Ana Guerra
- Department of Gastroenterology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Gloria Jiménez
- Department of Radiology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Marta Montes
- Department of Pathology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Fernando Arias
- Department of Radiotherapy, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Miguel A Ciga
- Coloproctology Unit, Department of General Surgery, Complejo Hospitalario de Navarra, Pamplona, Spain
| | | | - María Ederra
- Navarra Public Health Institute, Pamplona, Spain
| | - Beñat Arín
- Department of General Surgery, Hospital García Orcoyen, Estella, Spain
| | | | - Asunción Sanz
- Nurse Navigator, Colorectal Cancer Multidisciplinary Unit, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Ruth Vera
- Department of Medical Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| |
Collapse
|
9
|
Flamarique S, Campo M, Asín G, Pellejero S, Viúdez A, Arias F. Stereotactic body radiation therapy for liver metastasis from colorectal cancer: size matters. Clin Transl Oncol 2020; 22:2350-2356. [PMID: 32488803 DOI: 10.1007/s12094-020-02375-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Accepted: 05/07/2020] [Indexed: 12/16/2022]
Abstract
PURPOSE We analysed our initial experience with SBRT in liver metastasis from colorectal cancer at our institution. MATERIALS AND METHODS Between January/2014 and December/2017, 22 patients with 31 LMCCR were treated. Local control (LC) was assessed using the Kaplan-Meier and log-rank tests. We analysed potential prognostic factors for LC: sex, PTV size, number of LM and the radiation scheme. RESULTS Median age: 69 years. Prior chemotherapy or local liver treatments: 81.8% and 63.6% of patients, respectively. SBRT consisted of 3 × 20 Gy (42.9%) and 3 × 15 Gy (31.4%). There were 88.5% responses (57.1% CR and 31.4% PR). Median follow-up was 30 months. LC per lesion at 12 and 24 months was 85.3% and 61.8%, respectively. Tumour volumes > 30 cc correlated with worsened 2-year-control rates (90% vs 34.5%) (p = 0.005). There was only a patient with CTC-grade 3 toxicity. CONCLUSIONS Liver SBRT is a safe and effective treatment that achieves high local control rates. We found a significant correlation between larger LMCRC and worse local control.
Collapse
Affiliation(s)
- S Flamarique
- Radiation Oncology Department, Complejo Hospitalario de Navarra, Navarre, Spain
| | - M Campo
- Radiation Oncology Department, Complejo Hospitalario de Navarra, Navarre, Spain
| | - G Asín
- Radiation Oncology Department, Complejo Hospitalario de Navarra, Navarre, Spain
| | - S Pellejero
- Radiation Oncology Department, Complejo Hospitalario de Navarra, Navarre, Spain
| | - A Viúdez
- Radiation Oncology Department, Complejo Hospitalario de Navarra, Navarre, Spain.,Medical Oncology Department, Complejo Hospitalario de Navarra, Navarre, Spain
| | - F Arias
- Radiation Oncology Department, Complejo Hospitalario de Navarra, Navarre, Spain.
| |
Collapse
|
10
|
Irazusta A, Rodríguez-Camejo C, Jorcin S, Puyol A, Fazio L, Arias F, Castro M, Hernández A, López-Pedemonte T. High-pressure homogenization and high hydrostatic pressure processing of human milk: Preservation of immunological components for human milk banks. J Dairy Sci 2020; 103:5978-5991. [PMID: 32418693 DOI: 10.3168/jds.2019-17569] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2019] [Accepted: 02/19/2020] [Indexed: 12/15/2022]
Abstract
Human milk (HM) constitutes the first immunological barrier and the main source of nutrients and bioactive components for newborns. Immune factors comprise up to 10% of the protein content in HM, where antibodies are the major components (mainly IgA, IgG, and IgM). In addition, antibacterial enzymes such as lysozyme and immunoregulatory factors such as soluble cluster of differentiation 14 (sCD14) and transforming growth factor β2 (TGF-β2) are also present and play important roles in the protection of the infant's health. Donor milk processed in HM banks by Holder pasteurization (HoP; 62.5°C, 30 min) is a safe and valuable resource for preterm newborns that are hospitalized, but is reduced in major immunological components due to thermal inactivation. We hypothesized that high hydrostatic pressure (HHP) and high-pressure homogenization (HPH) are 2 processes that can be used on HM to reduce total bacteria counts while retaining immunological components. We studied the effects of HHP (400, 450, and 500 MPa for 5 min applied at 20°C) and HPH (200, 250, and 300 MPa, milk inlet temperature of 20°C) applied to mature HM, on microbiological and immunological markers (IgA, IgG, IgM, sCD14, and TGF-β2), and compared them with those of traditional HoP in HM samples from healthy donors. The HHP processing between 400 and 500 MPa at 20°C reduced counts of coliform and total aerobic bacteria to undetectable levels (<1.0 log cfu/mL) while achieving approximately 100% of immunological component retention. In particular, comparing median percentages of retention of immunological components for 450 MPa versus HoP, we found 101.5 versus 50.5% for IgA, 89.5 versus 26.0% for IgM, 104.5 versus 75.5% for IgG, 125.0 versus 72.5% for lysozyme, 50.6 versus 0.1% for sCD14, and 88.5 versus 61.1% for TGF-β2, respectively. Regarding HPH processing, at a pressure of 250 MPa and inlet temperature of 20°C, the process showed good potential to reduce coliforms to undetectable levels and total aerobic bacteria to levels slightly above those obtained by HoP. The median percentages of retention of immunological markers for HPH versus HoP were 71.5 versus 52.0%, 71.0 versus 27.0%, 104.0 versus 66.5%, and 30.9 versus 0.2%, for IgA, IgM, IgG, and sCD14, respectively; results did not significantly differ for lysozyme and TGF-β2. The HPH at 300 MPa produced higher inactivation of immunological components, similar to values achieved with HoP.
Collapse
Affiliation(s)
- A Irazusta
- Área de Tecnología de Alimentos, Departamento de Ciencia y Tecnología de Alimentos, Facultad de Química, Universidad de la República, Montevideo, Uruguay 11800
| | - C Rodríguez-Camejo
- Cátedra de Inmunología, Instituto de Química Biológica, Facultad de Ciencias-Área Inmunología, Departamento de Biociencias, Facultad de Química, Instituto de Higiene, Universidad de la República, Montevideo, Uruguay 11600
| | - S Jorcin
- Área de Tecnología de Alimentos, Departamento de Ciencia y Tecnología de Alimentos, Facultad de Química, Universidad de la República, Montevideo, Uruguay 11800
| | - A Puyol
- Banco de Leche "Ruben Panizza," Centro Hospitalario Pereira Rossell, Administración de los Servicios de Salud del Estado, Montevideo, Uruguay 11600
| | - L Fazio
- Banco de Leche "Ruben Panizza," Centro Hospitalario Pereira Rossell, Administración de los Servicios de Salud del Estado, Montevideo, Uruguay 11600
| | - F Arias
- Cátedra de Inmunología, Instituto de Química Biológica, Facultad de Ciencias-Área Inmunología, Departamento de Biociencias, Facultad de Química, Instituto de Higiene, Universidad de la República, Montevideo, Uruguay 11600
| | - M Castro
- Hospital de la Mujer, Centro Hospitalario Pereira Rossell, Administración de los Servicios de Salud del Estado, Montevideo, Uruguay 11600
| | - A Hernández
- Cátedra de Inmunología, Instituto de Química Biológica, Facultad de Ciencias-Área Inmunología, Departamento de Biociencias, Facultad de Química, Instituto de Higiene, Universidad de la República, Montevideo, Uruguay 11600
| | - T López-Pedemonte
- Área de Tecnología de Alimentos, Departamento de Ciencia y Tecnología de Alimentos, Facultad de Química, Universidad de la República, Montevideo, Uruguay 11800.
| |
Collapse
|
11
|
Campeny E, López-Pelayo H, Nutt D, Blithikioti C, Oliveras C, Nuño L, Maldonado R, Florez G, Arias F, Fernández-Artamendi S, Villalbí JR, Sellarès J, Ballbè M, Rehm J, Balcells-Olivero MM, Gual A. The blind men and the elephant: Systematic review of systematic reviews of cannabis use related health harms. Eur Neuropsychopharmacol 2020; 33:1-35. [PMID: 32165103 DOI: 10.1016/j.euroneuro.2020.02.003] [Citation(s) in RCA: 57] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/24/2019] [Accepted: 02/17/2020] [Indexed: 01/24/2023]
Abstract
Cannabis is the third most used psychoactive substance worldwide. The legal status of cannabis is changing in many Western countries, while we have very limited knowledge of the public health impact of cannabis-related harms. There is a need for a summary of the evidence of harms and risks attributed to cannabis use, in order to inform the definition of cannabis risky use. We have conducted a systematic review of systematic reviews, aiming to define cannabis-related harms. We included systematic reviews published until July 2018 from six different databases and following the PRISMA guidelines. To assess study quality we applied the AMSTAR 2 tool. A total of 44 systematic reviews, including 1,053 different studies, were eligible for inclusion. Harm was categorized in three dimensions: mental health, somatic harm and physical injury (including mortality). Evidence shows a clear association between cannabis use and psychosis, affective disorders, anxiety, sleep disorders, cognitive failures, respiratory adverse events, cancer, cardiovascular outcomes, and gastrointestinal disorders. Moreover, cannabis use is a risk factor for motor vehicle collision, suicidal behavior and partner and child violence. Cannabis use is a risk factor for several medical conditions and negative social consequences. There is still little data on the dose-dependency of these effects; evidence that is essential in order to define, from a public health perspective, what can be considered risky use of cannabis. This definition should be based on quantitative and qualitative criteria that informs and permits the evaluation of current approaches to a regulated cannabis market.
Collapse
Affiliation(s)
- E Campeny
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Grup Recerca Addiccions Clinic (GRAC-GRE) Psychiatry Department, Neurosciences Institute, Hospital Clínic, Universitat de Barcelona, Spain.
| | - H López-Pelayo
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Grup Recerca Addiccions Clinic (GRAC-GRE) Psychiatry Department, Neurosciences Institute, Hospital Clínic, Universitat de Barcelona, Spain
| | - D Nutt
- Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, UK
| | - C Blithikioti
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Grup Recerca Addiccions Clinic (GRAC-GRE) Psychiatry Department, Neurosciences Institute, Hospital Clínic, Universitat de Barcelona, Spain
| | - C Oliveras
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Grup Recerca Addiccions Clinic (GRAC-GRE) Psychiatry Department, Neurosciences Institute, Hospital Clínic, Universitat de Barcelona, Spain
| | - L Nuño
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Grup Recerca Addiccions Clinic (GRAC-GRE) Psychiatry Department, Neurosciences Institute, Hospital Clínic, Universitat de Barcelona, Spain
| | - R Maldonado
- Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain
| | - G Florez
- Hospital Universitario de Ourense, Ourense, Spain
| | - F Arias
- Hospital Doce de Octubre, Madrid, Spain
| | | | - J R Villalbí
- Public Health Agency of Barcelona, Barcelona, Spain
| | - J Sellarès
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Grup Recerca Addiccions Clinic (GRAC-GRE) Psychiatry Department, Neurosciences Institute, Hospital Clínic, Universitat de Barcelona, Spain
| | - M Ballbè
- Catalan Institute of Oncology, Barcelona, Spain; Institut d'Investigació Biomèdica de Bellvitge, Barcelona, Spain
| | - J Rehm
- Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, (CAMH), Canada; Campbell Family Mental Health Research Institute, CAMH, Canada; Addiction Policy, Dalla Lana School of Public Health, University of Toronto (UofT), Canada; Department of Psychiatry, Faculty of Medicine, UofT, Canada; Epidemiological Research Unit, Klinische Psychologie & Psychotherapie, Technische Universität Dresden, Dresden, Germany; Department of International Health Projects, Institute for Leadership and Health Management, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
| | - M M Balcells-Olivero
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Grup Recerca Addiccions Clinic (GRAC-GRE) Psychiatry Department, Neurosciences Institute, Hospital Clínic, Universitat de Barcelona, Spain
| | - A Gual
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Grup Recerca Addiccions Clinic (GRAC-GRE) Psychiatry Department, Neurosciences Institute, Hospital Clínic, Universitat de Barcelona, Spain
| |
Collapse
|
12
|
Abstract
Abdominal lipoblastomas are uncommon soft tissue tumors in children and rarely arise from the mesentery. Due to intraabdominal location and slow growth, these masses can go unnoticed for long periods of time and often found on surgical exploration. We present a case of a 12-year-old male with years of abdominal distension accompanied by new onset early satiety that was found to have an intra-abdominal mass. He underwent an exploratory laparotomy revealing a large 33 x 27 x 15 cm rubbery mesenteric mass displacing the entire intra-abdominal contents, connected by a single vascular pedicle and encasing a loop of small intestine. The mass was resected and the patient did well without signs of recurrence. Histology confirmed the presence of mature adipocytes but on further cytogenetic analysis, a translocation between chromosomes 2 and 8 at the 12q arm was detected, which is often associated with lipoblastomas. This case represents the one of the largest mesenteric lipoblastomas that matured extensively to lipoma-like histology at the time of surgical resection.
Collapse
Affiliation(s)
- Anthony I Squillaro
- Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States
| | - Monica D Chow
- Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States
| | - Fernando Arias
- Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States
| | - Evita T Sadimin
- Department of Pathology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States
| | - Yi-Horng Lee
- Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States.,Division of Pediatric Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States
| |
Collapse
|
13
|
Flamarique S, Campo M, Asín G, Zubimendi C, Arias F. [Re-irradiation with SBRT (Stereotactic Body Radiation Therapy) for locoregional unresectable relapse of head and neck cancer: a case report]. An Sist Sanit Navar 2019; 42:339-343. [PMID: 31343640 DOI: 10.23938/assn.0715] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Patients with an unresectable recurrence of head and neck carcinoma (HNC) have a poor prognosis, with limited treatment options. Recent technical advances allow radiotherapy (RT) to be handled with great precision, making it possible to re-irradiate recurrent tumors by means of stereotactic body radiotherapy (SBRT) with high doses of RT while protecting healthy tissues near the tumor. Although this technique has been used to irradiate different primary tumors and their metastases, SBRT in HNC has had a much slower evolution than in the mentioned locations. This is due to the difficulties in re-irradiating the HNC, because of the expected toxicity as it is a relatively small area with dense vascularization and innervation, and where several senses are located. We present the first case of a HNC re-irradiated with SBRT in the Complejo Hospitalario de Navarra; the patient showed a complete response and continues to be disease-free sixteen months after the irradiation.
Collapse
Affiliation(s)
- S Flamarique
- Servicio de Oncología Radioterápica. Complejo Hospitalario de Navarra. Pamplona..
| | | | | | | | | |
Collapse
|
14
|
Amofa Sr. P, Arias F, Trifilio E, Belser-Ehrlich J, Rohl B, Lopez F, Levy SA. Free Neurocognitive Screening Initiative: An Opportunity to Address Health Disparities and Promote Cultural Competence in Northcentral Florida. Arch Clin Neuropsychol 2019. [DOI: 10.1093/arclin/acz029.61] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Objective
The risk for cognitive impairment is greater in individuals with low SES and limited education. In rural areas, distance and economic concerns preclude individuals from accessing care. In Alachua County, 23% of residents live below poverty and 16% are uninsured. The Neurocognitive Screening Initiative (NSI) attempts to reduce disparities in Alachua by offering free neurocognitive screening. NSI also aspires to promote cultural competence through unique training opportunities for clinical neuropsychology doctoral students.
Method
Patients learned about NSI through flyers, word of mouth, or referrals. Appointments include a clinical interview, cognitive testing, and mood questionnaires. Patients receive feedback, brain health recommendations, and referrals to community resources. Phase 1 began in November 2017 and involved selection of appropriate cognitive measures, development and dissemination of advertising materials, identification of resources, and trainee recruitment. From February 2018 to August 2018, phase 2 involved administration of cognitive screeners. Phase 3 involved continued provision of clinical services, expansion of the NSI team and increased culturally relevant outreach.
Outcomes
NSI’s greatest challenge is recruitment of the appropriate demographic. Since phase 2, we have evaluated 10 patients with diverse racial, socioeconomic, and clinical characteristics. NSI has recruited an ethnoracially diverse cohort of trainees comprised of 4 graduate students and 2 postdoctoral fellows supervised by a clinical neuropsychologist.
Discussion
Efforts to provide services to marginalized individuals have uncovered challenges in attracting patients who might benefit from these services. NSI is forging community partnerships with churches, libraries, and local organizations to reach the targeted audience. Via weekly meetings, participation in community events/outreach, and clinical work, NSI provides unique training for emerging neuropsychologists.
Collapse
|
15
|
Carrión CI, Arias F, Diaz-Santos M, Levy SA, Hill-Jarrett TG, Avila J, Jones R, Rivera Mindt M, Arce M, Schupf N, Mayeux R, Manly J. Does Literacy Moderate the Relationship between Age of Migration and Cognitive Change: Results from the Washington Heights-Inwood Community Aging Project (WHICAP). Arch Clin Neuropsychol 2019. [DOI: 10.1093/arclin/acz029.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Objective
The “healthy immigrant effect” pertains to findings that Hispanics/Latinos born outside of the US tend to be physically and emotionally healthier than individuals born in the US. However, immigrant Latino groups residing in the US have higher incidences of dementia (Tang et al., 2001). Sex/gender and years of education have been found to moderate the relationship between age of migration and cognitive functioning among immigrants born in Mexico (Garcia et al., 2017; Hill et al., 2012). While years of education has been the focus of many studies, literacy (ability to read/write) has been less frequently explored as a moderator of age of migration and cognitive change. We investigated the effect of age of migration on cognitive trajectory in a diverse Latino population and explored whether literacy influences the association between age of immigration and cognitive change. We hypothesize that literacy (ability to read/write) will buffer the effects of age of migration on cognitive (memory, language, motor speed, visuospatial) trajectory.
Participants and Method
Age at baseline, English fluency, country of birth, sex/gender, and years of education were included as time-invariant covariates and literacy was tested as a moderator via multiple group modeling.
Results
Results show that age of migration is marginally and inversely associated with baseline cognitive performance (p < .01). Thus, individuals who immigrated at an older age had lower baseline cognitive scores than their counterparts. Age of migration was not associated with cognitive change. Independent of covariates, literacy did not buffer the negative effects of later age at migration on cognitive function.
Conclusions
Results suggest that literacy confers a small advantage in premorbid cognition, but does not protect against cognitive decline over time. These findings also suggest that adults who immigrate at an older age present with lower cognitive scores at baseline, but do not experience faster rates of cognitive change.
References
Tang, M. X., Cross, P., Andrews, H., Jacobs, D. M., Small, S., Bell, K., ... & Mayeux, R. (2001). Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology, 56, 49-56. Garcia, M. A., Reyes, A. M., Downer, B., Saenz, J. L., Samper-Ternent, R. A., & Raji, M. (2018). Age of migration and the incidence of cognitive impairment: A cohort study of elder Mexican-Americans. Innovation in aging, 1, igx037. https://doi.org/10.1093/geroni/igx037. Hill, T. D., Angel, J. L., Balistreri, K. S., & Herrera, A. P. (2012). Immigrant Status and Cognitive Functioning in Late Life: An Examination of Gender Variations in the Healthy Immigrant Effect. Social Science & Medicine (1982), 75, 2076–2084. http://doi.org/10.1016/j.socscimed.2012.04.005.
Collapse
|
16
|
Olsen J, Arnsten J, Scott T, Arias F, Zhang C, Rivera Mindt M. The Role of Quality of Education in Neurocognitive Functioning in a Diverse Sample with Chronic Opioid Use Disorder. Arch Clin Neuropsychol 2019. [DOI: 10.1093/arclin/acz029.36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Objective
Literacy is a proxy for quality of education (QoE) and mediates ethnicity-related differences in neurocognitive (NC) performance in some populations (Manly et al., 2002; Rivera Mindt et al., 2008). However, it is unknown whether this relationship exists in the context of chronic opioid use disorder (OUD). This study examined the role of ethnicity, QoE, opioid use severity, and depression in predicting NC performance in a diverse sample of persons with OUD.
Participants and Method
This cross-sectional study included 74 adults with OUD (Age M = 40.3 [SD = 10.5]; Education M = 11.3 [2.5]; 24% female; 68% Latinx and 32% Non-Latinx White [NLW]). All participants completed comprehensive NC testing and psychiatric/substance use questionnaires. Variables included ethnicity (Latinx vs. Non-Latinx White), years of education, QoE (Wide Range Achievement Test, Third Edition; WRAT-3 Reading Standard Scores), opioid use severity (high vs. low OAT dose), current depression (Beck Depression Inventory, Second Edition; BDI-II Total Score), and demographically-corrected NC T-scores were computed and used for average domain T-scores (e.g., learning, memory, verbal fluency, executive function). Bivariate and ANCOVA analyses were used to compare ethnic groups.
Results
There were no significant group differences on opioid use severity or current depression (p’s > .05). However, compared to the NLW group, the Latinx group had lower years of education (M = 10.9 [SD = 1.7] vs. M = 12.2 [SD = 3.5]; t[72)] = 2.1, p < .05), QoE (M = 83.1 [SD = 13.6] vs. M = 94.8 [SD = 9.4]; t[72] = 3.8, p < .001), executive functioning (M = 42.0 [SD = 6.5] vs. M = 45.8 [SD = 8.5]; t[72) = 2.1, p < .05), and learning (M = 32.2 [SD = 8.2] vs. M = 37.8 [SD = 8.7]; t[72)] = 2.7, p < .05), with medium to large effect sizes (Cohen’s d > .50). The overall effect of ethnicity became non-significant for executive functioning after accounting for QoE (F[2,70] = 10.0, p = .002) and years of education (F[2,70)] = 16.8, p < .001).
Conclusions
The current study found that accounting for years of education and QoE attenuates some differences in NC performance between Latinx and Non-Latinx participants.
References
Manly, J. J., Jacobs, D. M., Touradji, P., Small, S. A., & Stern, Y. (2002). Reading level attenuates differences in neuropsychological test performance between African American and White elders. Journal of the International Neuropsychological Society, 8(3), 341-348. Mindt, M. R., Arentoft, A., Germano, K. K., D’Aquila, E., Scheiner, D., Pizzirusso, M., ... & Gollan, T. H. (2008). Neuropsychological, cognitive, and theoretical considerations for evaluation of bilingual individuals. Neuropsychology review, 18(3), 255-268.
Collapse
|
17
|
Arias F, Asín G, Flamarique S, Hernández I, Suarez J. In favor of total neoadjuvant therapy (TNT) for locally advanced rectal carcinoma. Clin Transl Oncol 2019; 22:793-794. [PMID: 31309436 DOI: 10.1007/s12094-019-02177-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2019] [Accepted: 07/03/2019] [Indexed: 11/25/2022]
Affiliation(s)
- F Arias
- Services of Radiation Oncology, Multidisciplinary Colorectal Cancer Unit (UMDCR), Complejo Hospitalario de Navarra, Pamplona, Spain.
| | - G Asín
- Services of Radiation Oncology, Multidisciplinary Colorectal Cancer Unit (UMDCR), Complejo Hospitalario de Navarra, Pamplona, Spain
| | - S Flamarique
- Services of Radiation Oncology, Multidisciplinary Colorectal Cancer Unit (UMDCR), Complejo Hospitalario de Navarra, Pamplona, Spain
| | - I Hernández
- Services of Medical Oncology, Multidisciplinary Colorectal Cancer Unit (UMDCR), Complejo Hospitalario de Navarra, Pamplona, Spain
| | - J Suarez
- Services of Surgery, Multidisciplinary Colorectal Cancer Unit (UMDCR), Complejo Hospitalario de Navarra, Pamplona, Spain
| |
Collapse
|
18
|
Barrado M, Blanco-Luquin I, Navarrete PA, Visus I, Guerrero-Setas D, Escors D, Kochan G, Arias F. Radiopotentiation of enzalutamide over human prostate cancer cells as assessed by real-time cell monitoring. Rep Pract Oncol Radiother 2019; 24:221-226. [PMID: 30858765 DOI: 10.1016/j.rpor.2019.02.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2018] [Revised: 12/12/2018] [Accepted: 02/07/2019] [Indexed: 11/29/2022] Open
Abstract
Aim To evaluate the radiopotentiation of enzalutamide in human prostate cancer cells. Background While radiotherapy is the first line of treatment for prostate cancer, androgen blockade therapies are demonstrating significant survival benefit as monotherapies. As androgen blockade can cause cell death by apoptosis, it is likely that androgen blockade will potentiate the cytotoxic activities of radiotherapy. Materials and methods Here, we tested the potential synergistic effects of these two treatments over two human metastatic prostate cancer cells by real-time cell analysis (RTCA), androgen-sensitive LNCaP cells (Lymph Node Carcinoma of the Prostate) and androgen-independent PC-3. Both cell lines were highly resistant to high doses of radiotherapy. Results A pre-treatment of LNCaP cells with IC50 concentrations of enzalutamide significantly sensitized them to radiotherapy through enhanced apoptosis. In contrast, enzalutamide resistant PC-3 cells were not sensitized to radiotherapy by androgen blockade. Conclusions These results provide evidence that the enzalutamide/radiotherapy combination could maximize therapeutic responses in patients with enzalutamide-sensitive prostate cancer.
Collapse
Affiliation(s)
- Marta Barrado
- Biomedical Research Center of Navarra-Navarrabiomed, Fundación Miguel Servet, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain.,Department of Radiation Oncology, Hospital of Navarre, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain
| | - Idoia Blanco-Luquin
- Biomedical Research Center of Navarra-Navarrabiomed, Fundación Miguel Servet, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain
| | - Paola Andrea Navarrete
- Department of Radiation Oncology, Hospital of Navarre, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain
| | - Ignacio Visus
- Department of Radiation Oncology, Hospital of Navarre, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain
| | - David Guerrero-Setas
- Biomedical Research Center of Navarra-Navarrabiomed, Fundación Miguel Servet, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain
| | - David Escors
- Biomedical Research Center of Navarra-Navarrabiomed, Fundación Miguel Servet, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain.,Department of Infection and Immunity, Rayne Institute, University College London, 5 University Street, WC1E 6JJ London, United Kingdom
| | - Grazyna Kochan
- Biomedical Research Center of Navarra-Navarrabiomed, Fundación Miguel Servet, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain
| | - Fernando Arias
- Department of Radiation Oncology, Hospital of Navarre, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain
| |
Collapse
|
19
|
Bakuła Z, Arias F, Bachiyska E, Borroni E, Cirillo DM, Coulter C, Giske C, Humięcka J, Van Ingen J, Ioannidis P, Kranzer K, Kuzmič U, Levina K, Lillebæk T, Mokrousov I, Morimoto K, Nikolayevskyy V, Norman A, Papaventsis D, Peuchant O, Safianowska A, Ulmann V, Vasiliauskiene E, Won-Jung K, Zhuravlev V, Žolnir-Dovč M, Krenke R, Jagielski T. MOLECULAR TYPING OF MYCOBACTERIUM KANSASII — A GLOBAL PERSPECTIVE. ACTA ACUST UNITED AC 2019. [DOI: 10.15789/2220-7619-2018-4-6.5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- Z. Bakuła
- Department of Applied Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw
| | - F. Arias
- Mycobacteria Laboratory, Public Health Institute of Chile, Santiago
| | - E. Bachiyska
- National Reference Laboratory for Tuberculosis, Sofia
| | - E. Borroni
- Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Milano
| | - D. M. Cirillo
- Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Milano
| | - C. Coulter
- Queensland Mycobacterial Reference Laboratory, Queensland, Brisbane
| | - C. Giske
- Department of Clinical Microbiology, Karolinska University Hospital, Solna
| | - J. Humięcka
- Hospital of Infectious Diseases in Warsaw, Warsaw
| | - J. Van Ingen
- Department of Medical Microbiology, Radboud University Medical Center, Nijmegen
| | - P. Ioannidis
- National Reference Laboratory for Mycobacteria, “Sotiria” Chest Diseases Hospital of Athens
| | - K. Kranzer
- National Reference Center for Mycobacteria, Forschungszentrum Borstel, Leibniz-Zentrum für Medizin und Biowissenschaften, Borstel
| | - U. Kuzmič
- Laboratory for Mycobacteria, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik
| | - K. Levina
- Mycobacteriology Section Laboratory, North Estonia Medical Centre, Tallinn
| | - T. Lillebæk
- International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen
| | - I. Mokrousov
- Laboratory of Molecular Microbiology, St. Petersburg Pasteur Institute, St. Petersburg
| | - K. Morimoto
- Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo
| | | | - A. Norman
- International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen
| | - D. Papaventsis
- National Reference Laboratory for Mycobacteria, “Sotiria” Chest Diseases Hospital of Athens
| | - O. Peuchant
- Laboratoire de Bactériologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux
| | - A. Safianowska
- Department of Internal Medicine, Pulmonary Diseases & Allergy, Warsaw Medical University, Warsaw
| | | | - E. Vasiliauskiene
- Infectious Diseases and Tuberculosis Hospital, Vilnius University Hospital Santariskiu Klinikos
| | - K. Won-Jung
- Division of Pulmonary and Critical Care Medicine; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine
| | - V. Zhuravlev
- Research Institute of Phthisiopulmonology, St. Petersburg
| | - M. Žolnir-Dovč
- Laboratory for Mycobacteria, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik
| | - R. Krenke
- Department of Internal Medicine, Pulmonary Diseases & Allergy, Warsaw Medical University, Warsaw
| | - T. Jagielski
- Department of Applied Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw
| |
Collapse
|
20
|
Trujillo CG, Domínguez C, Robledo D, Caicedo JI, Bravo-Balado A, Cataño JG, Cortés N, Parra L, Riaño W, Londoño-Schimmer E, Otero J, Herrera G, Arias F, Plata M. Urological approach for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a clinical care center. Acta Chir Belg 2018; 118:348-353. [PMID: 29475412 DOI: 10.1080/00015458.2018.1436797] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
BACKGROUND Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is associated with significant manipulation of the urinary tract (UT). We aim to describe the urological events and their management in patients who underwent CRS-HIPEC. METHODS Clinical records of patients who underwent treatment between 2007 and 2015 were reviewed. Urological events and their multidisciplinary management were analyzed. Descriptive statistics were calculated. RESULTS A total of 103 patients were included. Mean age was 51 years (SD ± 11.8). Mean peritoneal cancer index (PCI) was 20.4 (SD ± 10.1). Primary tumors included appendicular (64%), gynecological (16%), colorectal (10%), and peritoneal mesotheliomas (9%). Ninety-three percent of patients had bilateral ureteral catheters inserted prior to surgery, without complications. Intraoperative UT injuries occurred in 7% of patients. In 5% of patients, tumor invasion of the bladder was evident at surgery and partial resection and primary repair of the bladder wall was performed. Urological complications included urinary tract infection (UTI) (21%) acute post-renal failure (4%), urinary fistulae (4%), and acute urinary retention (AUR) (1%). CONCLUSIONS In our study, intraoperative UT events and postoperative complications, although not neglectable, were infrequent. Due to the high complexity of these cases, a multidisciplinary approach is mandatory. However, randomized clinical trials are necessary to clarify current data on the need and efficacy of prophylactic ureteral catheterization in patients undergoing CRS-HIPEC.
Collapse
Affiliation(s)
- Carlos Gustavo Trujillo
- Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia
| | - Cristina Domínguez
- Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia
| | - Daniela Robledo
- Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia
| | - Juan Ignacio Caicedo
- Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia
| | - Alejandra Bravo-Balado
- Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia
| | - Juan Guillermo Cataño
- Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia
| | - Natalia Cortés
- Department of Surgery, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
| | - Lina Parra
- Department of Surgery, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
| | - Wilson Riaño
- Department of Surgery, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
| | - Eduardo Londoño-Schimmer
- Department of Surgery, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
- Clinical Care Center for Peritoneal Neoplasms, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
| | - Jorge Otero
- Clinical Care Center for Peritoneal Neoplasms, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
- Department of Oncology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
| | - Gabriel Herrera
- Department of Surgery, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
- Clinical Care Center for Peritoneal Neoplasms, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
| | - Fernando Arias
- Department of Surgery, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
- Clinical Care Center for Peritoneal Neoplasms, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
| | - Mauricio Plata
- Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia
| |
Collapse
|
21
|
Arias F, Londoño-Schimmer E, Otero J, Cétares C, Herrera G, Mora M, Rodriguez P, Mejía M, Guerra J, Ruiz-Patiño A, Cardona Zorrilla A. Long-term outcomes with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis: 10-year experience in a developing country. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy281.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
22
|
Campo M, Flamarique S, Asin G, Visus I, Lacalle A, Maneru F, Zubimendi C, Resano M, Saenz J, Arias F. Multidisciplinary approach of a locally advanced adult alveolar rhabdomyosarcoma of paranasal sinuses: a case report and literature review. RHINOL 2018. [DOI: 10.4193/rhinol/18.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
|
23
|
Cabrera Rodríguez J, Cacicedo J, Giralt J, García Miragall E, Lloret M, Arias F, González Ruiz MA, Contreras J. GEORCC recommendations on target volumes in radiotherapy for Head Neck Cancer of Unkown Primary. Crit Rev Oncol Hematol 2018; 130:51-59. [PMID: 30196912 DOI: 10.1016/j.critrevonc.2018.07.006] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2017] [Revised: 04/16/2018] [Accepted: 07/17/2018] [Indexed: 12/22/2022] Open
Abstract
Head Neck Cancer of Unknown Primary (HNCUP) is a rare condition, representing approximately 5-10% of all head neck cancers. Radiotherapy, adjuvant or radical, is usually employed in the treatment of those patients. To date, no specific guidelines for the optimal definition of the target volume to be irradiated have been published. In recent years, there have been advances in the knowledge of the molecular biology of HNCUP, its diagnostic imaging and the implementation of sophisticated radiotherapy techniques with enhanced precision in target localization and treatment delivery. These progresses have provided valuable information about the natural history of HNCUP that will allow for establishment of the best treatment for each patient, including standardized, consistent and reproducible target volumes definitions. Several recommendations regarding how to choose volumes when contouring HNCUP in clinical practice are reported, in order to achieve a high rate of loco-regional control while avoiding unnecessary toxicity.
Collapse
Affiliation(s)
- Joaquín Cabrera Rodríguez
- Radiation Oncology Department, Hospital Universitario Infanta Cristina, Avenida de Elvas, s/n, 06080 Badajoz, Spain.
| | - Jon Cacicedo
- Radiation Oncology Department, Hospital Universitario de Cruces, Plaza de Cruces, s/n, 48903 Baracaldo, Spain
| | - Jordi Giralt
- Radiation Oncololgy Deparment, Hospital General Vall D'Hebron, Passeig de la Vall d'Hebron, 119-129, 08035 Barcelona, Spain
| | - Enrique García Miragall
- Radiation Oncology Department, Hospital General Universitario Valencia- ERESA, Avenida Blasco Ibáñez, 17, 46010 Valencia, Spain
| | - Marta Lloret
- Radiation Oncology Department, Hospital Universitario Doctor Negrín, c/ Barranco de la ballena, s/n, 35010, Las Palmas de Gran Ganaria, Spain
| | - Fernando Arias
- Radiation Oncology Department, Complejo Hospitalario de Navarra, C/ Irunlarrea, 4, 31008 Pamplona, Spain
| | - María Angeles González Ruiz
- Radiation Oncology Department, Hospital Universitario Infanta Cristina, Avenida de Elvas, s/n, 06080 Badajoz, Spain
| | - Jorge Contreras
- Radiation Oncology Department, Complejo Hospitalario Carlos Haya, Avenida de Carlos Haya, s/n, 29010 Málaga, Spain
| |
Collapse
|
24
|
Barrado M, Escors D, Arias F, Blanco I, Arteta V, Visus I, Campo M, Flamarique S, Navarrete P, Martínez E. Enzalutamide as a Radiosensitizer in Prostate Cancer Cell Lines. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.1111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
25
|
Mañós M, Giralt J, Rueda A, Cabrera J, Martinez-Trufero J, Marruecos J, Lopez-Pousa A, Rodrigo J, Castelo B, Martínez-Galán J, Arias F, Chaves M, Herranz J, Arrazubi V, Baste N, Castro A, Mesía R. Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1). Oral Oncol 2017; 70:58-64. [DOI: 10.1016/j.oraloncology.2017.04.004] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2017] [Revised: 03/31/2017] [Accepted: 04/08/2017] [Indexed: 01/15/2023]
|
26
|
Arias F, Eito C, Asín G, Mora I, Cambra K, Mañeru F, Ibáñez B, Arbea L, Viudez A, Hernández I, Arrarás JI, Errasti M, Barrado M, Campo M, Visus I, Flamarique S, Ciga MA. Fecal incontinence and radiation dose on anal sphincter in patients with locally advanced rectal cancer (LARC) treated with preoperative chemoradiotherapy: a retrospective, single-institutional study. Clin Transl Oncol 2017; 19:969-975. [DOI: 10.1007/s12094-017-1627-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2016] [Accepted: 02/02/2017] [Indexed: 01/13/2023]
|
27
|
Ureña I, Arias F, Castro M, León E, Masís M, Reyes L. Development of a methodology to quantify bromacil in hair using an animal model. Toxicol Lett 2016. [DOI: 10.1016/j.toxlet.2016.07.215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
28
|
Arias F, Asín G, Viúdez A. Clinical guide SEOM: hepatocellular carcinoma (HCC): considerations on SBRT. Clin Transl Oncol 2016; 18:955-6. [DOI: 10.1007/s12094-016-1501-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2016] [Accepted: 03/08/2016] [Indexed: 10/22/2022]
|
29
|
Pinedo P, Melendez P, Paudyal S, Krauss R, Arias F, Lopez H, Luco A, Vergara C. Association between disease occurrence and fertility of dairy cows in three geographic regions of Chile. Theriogenology 2016; 86:817-23. [DOI: 10.1016/j.theriogenology.2016.03.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2015] [Revised: 02/18/2016] [Accepted: 03/02/2016] [Indexed: 11/15/2022]
|
30
|
Manterola A, Asín G, Arias F, Errasti M, Barrado M, Campo M, Visus I, Domínguez M. EP-1192: Management of the axilla after neoadjuvant systemic therapy in breast cancer: A systematic revision. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32442-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
31
|
Arias F, Eito C, Asín G, Mora I, Cambra K, Mañeru F, Ibáñez B, Arbea L, Errasti M, Barrado M, Campo M, Visus I, García-Escobedo J, Torres C, Ciga M. EP-1288: Sphincter function and dose of radiation in rectal cancer. A Single-Institutional study. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32538-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
32
|
Rico Oses M, Martinez E, Bermejo B, Villafranca E, Navarrete P, Errasti M, Barrado M, Campo M, Visus I, Flamarique S, Bragado L, Manterola A, Sola A, Pellejero S, Asin G, Dominguez M, Mañeru F, Arias F. EP-1766: Factors influencing on intrafraction variation in lung Stereotactic Body Radiation Therapy. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)33017-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
33
|
Arias F, Eito C, Viudez A, Asin G, Ibañez B, Hernandez I, Cambra K, Errasti M, Barrado M, Campo M, Visus I, Mata E, Ciga M. Effects of adjuvant oxaliplatin on anal function in locally advanced rectal cancer treated with preoperative chemoradiotherapy and low anterior resection. J Clin Oncol 2016. [DOI: 10.1200/jco.2016.34.4_suppl.718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
718 Background: The main purpose of the present study was to determine if the addition of adjuvant oxaliplatin (OXA) could have some influence on sphincter function in patients with locally advanced rectal cancer (LARC) treated with preoperative capecitabine/radiotherapy followed by lower anterior resection (LAR). Methods: Those patients with LARC treated at our center with LAR and without two-years loco-regional relapse were retrospectively analyzed independent of the type of adjuvant treatment received. Anal sphincter function was assessed by Wexner´s incontinence score (0 to 20 points, being punctuation inversely proportional to sphincter function). All questionnaires were completed between January 2010 and December 2012. Comparisons of sphincter function measured with the Wexner test between patients with and without OX were conducted with the Mann-Whitney test. Statistical analyses were conducted using IBM SPSS Statistics, version 20. Results: From 2006, 92 consecutive patients were included in our study. Mean time from LAR to fecal function assessment was 58 months (25 to 96 months). Wexner test median values did not differ significantly (p=0.450) between patients with and without adjuvant OXA. The median (IQR) for the group without adjuvant OXA was 6.0 (1.0-11.25), being for group that received adjuvant OXA of 5.0 (1.0-10.0). Conclusions: Based on our findings, OXA could be used as adjuvant treatment in LARC, due to its absent of deleterious influence over the sphincter anal function. Because of the retrospective nature of our study, prospective studies should be warranted in similar scenarios. This study has been supported by a grant of “Mutua Madrileña Fundation.”
Collapse
Affiliation(s)
| | - Clara Eito
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Antonio Viudez
- Medical Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Gemma Asin
- Department of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Berta Ibañez
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Irene Hernandez
- Service of Medical Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Koldo Cambra
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | | | | | - Maider Campo
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | | | - Elena Mata
- Medical Oncology, Hospital Reina Sofia, Tudela, Spain
| | - Miguel Ciga
- Complejo Hospitalario de Navarra, Pamplona, Spain
| |
Collapse
|
34
|
Manterola A, Asin G, Arias F, Errasti M, Barrado M, Campo M, Visus I, Dominguez MA. Current Status of Radiotherapy for the Management of Regional Nodes in Breast Cancer. Clin Breast Cancer 2015; 16:1-7. [PMID: 26464208 DOI: 10.1016/j.clbc.2015.09.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2015] [Revised: 08/25/2015] [Accepted: 09/11/2015] [Indexed: 12/01/2022]
Abstract
Worldwide, breast cancer is the most common invasive cancer in women. Breast cancer constitutes about 23% of invasive cancers in women. The management of breast cancer depends on various factors, including the cancer stage and patient age. Breast cancer is usually treated with surgery, which can be followed by chemotherapy or radiation therapy, or both. Until recently, the standard procedure for axillary study was axillary dissection. Sentinel lymph node biopsy has been validated as a less-aggressive axillary treatment without an impact on survival. In the present report, we review the current management of the axillary lymph nodes, especially from the viewpoint of an oncology radiotherapist.
Collapse
Affiliation(s)
- Ana Manterola
- Department of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain.
| | - Gemma Asin
- Department of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Fernando Arias
- Department of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Marta Errasti
- Department of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Marta Barrado
- Department of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Maider Campo
- Department of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Ignacio Visus
- Department of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | | |
Collapse
|
35
|
Sanz E, Hevia V, Arias F, Fabuel JJ, Álvarez S, Rodríguez-Patrón R, Gómez V, Díez-Nicolás V, González-Gordaliza C, Burgos FJ. Contrast-enhanced ultrasound (CEUS): an excellent tool in the follow-up of small renal masses treated with cryoablation. Curr Urol Rep 2015; 16:469. [PMID: 25404183 DOI: 10.1007/s11934-014-0469-3] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Strict imaging follow-up is mandatory after cryoablation of small renal masses (SRMs). Although it uses ionizing radiation and nephrotoxic iodinated contrast, computed tomography (CT) is still the gold standard test. Contrast-enhanced ultrasound (CEUS) is a novel technique that informs in real time about renal perfusion avoiding radiation and nephrotoxicity. The objective of this study is to compare outcomes between CEUS and CT in the follow-up of SRMs treated with cryoablation, as well as to assess degree of agreement between them. This is a prospective observational study (May 2012 to December 2013) comparing CEUS and CT in 16 patients with SRMs cryoablated. The on-going protocol of the study includes a CT and CEUS 3 months after treatment and then every 6 months during 5 years. Local relapse was defined as the presence of contrast enhancement in the mass. All the CEUS were performed by a single experienced observer (E.S.). Degree of agreement was measured with kappa index. CEUS detected contrast enhancement in three patients (3/16, 18.8%) and CT in two patients (2/16, 12.5%). Degree of agreement between CEUS and CT, according to Landis-Koch classification, was 0.76 (CI 0.33-1.19; p = 0.0165), which is excellent and higher than expected by random. Sensitivity of the test is 93.75% (15/16). Median time of follow-up after cryoablation is 22 months (15.5-36.5). CEUS has an excellent agreement with CT and a high sensitivity in the follow-up of SRMs treated with cryosurgery, demonstrating its usefulness. Due to these encouraging results, it could become a reference test in the near future for monitoring SRMs after ablative treatment.
Collapse
Affiliation(s)
- Enrique Sanz
- Urology Department, Hospital Universitario Ramón y Cajal, Alcalá University, Madrid, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Baena-del-Valle J, Palau-Lázaro M, Mejía-Arango M, Otero J, Londoño-Schimmer E, Cortes N, Pozo M, Herrera-Almario G, Arias F, Rodriguez-Urrego P. Well differentiated neuroendocrine tumor of the appendix and low-grade appendiceal mucinous neoplasm presenting as a collision tumor. Rev Esp Enferm Dig 2015; 107:396-398. [PMID: 26031879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
|
37
|
Arias F, Eito C, Mora I, Cambra K, Mañeru F, Ibañez B, Arbea L, Viudez A, Errasti M, Barrado M, Ciga M, Asin G. Effect of the dose of radiation (RT) to the anal sphincter on the sphincter function of patients with locally advanced rectal cancer (LARC) treated with preoperative chemoradiotherapy followed by low anterior resection (LAR) with total mesorectum excision (TME). J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.e14595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | - Clara Eito
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Itxaso Mora
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Koldo Cambra
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | | | - Berta Ibañez
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Leire Arbea
- Radiation Oncology, Clinica Universidad de Navarra, Pamplona, Spain
| | - Antonio Viudez
- Complejo Hospitalario de Navarra, Medical Oncology, Pamplona, Spain
| | | | | | - Miguel Ciga
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Gemma Asin
- Department of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| |
Collapse
|
38
|
Arias F, Hernández I, Asín G, Contreras J, Villar E, Pérez A, Casado V, Bonfill T, Vera R. PO-092: Phase II study of TPF and cetuximab+RT in locally advanced laryngeal/hypopharyngeal carcinoma. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)34852-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
39
|
Arias F, Herrera-Almario G, Pozo ME, Londoño-Schimmer E, Otero JM, Cardona A, Cortes N, Mora M. Safety and Quality Outcomes in Peritoneal Surface Malignancy Patients: Developing a National Center for Excellence in Colombia. Ann Surg Oncol 2014; 22:1733-8. [DOI: 10.1245/s10434-014-4064-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2014] [Indexed: 12/26/2022]
|
40
|
Arias F, Bender H. DGR-1 * Neuropsychological Assessment of Non-Native English Speaking Prospective Organ Transplant Recipients: A Case Series. Arch Clin Neuropsychol 2014. [DOI: 10.1093/arclin/acu035.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
41
|
Arias F, Asin G, Mora I, Cambra K, Ibañez B, Mañeru F, Viudez A, Hernandez I, Arbea L, Errasti M, Barrado M, Eito C, Ciga M, Vera R, Dominguez MA. Does adjuvant oxaliplatin affect the sphincter function in patients with locally advanced rectal cancer (LARC) treated with preoperative chemoradiotherapy followed by low anterior resection (LAR) with total mesorectum excision (TME)? J Clin Oncol 2014. [DOI: 10.1200/jco.2014.32.15_suppl.e14585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | - Gemma Asin
- Department of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Itxaso Mora
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Koldo Cambra
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Berta Ibañez
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | | | - Antonio Viudez
- Complejo Hospitalario de Navarra, Medical Oncology, Pamplona, Spain
| | - Irene Hernandez
- Service of Medical Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Leire Arbea
- Radiation Oncology, Clinica Universidad de Navarra, Pamplona, Spain
| | | | | | - Clara Eito
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Miguel Ciga
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Ruth Vera
- Service of Medical Oncology, Hospital de Navarra, Pamplona, Spain
| | | |
Collapse
|
42
|
Arias F, Herruzo I, Contreras J, de las Heras M, Garcia Saenz JA, de la Torre A, Romero J, Arrazubi V, Prieto I, Calvo FA. Postsurgical erlotinib and cisplatin concurrent chemoradiotherapy (CRT) promotes favorable outcomes in high-risk locally advanced head and neck squamous-cell cancer (LAHNSCC): A GICOR Working Group trial. J Clin Oncol 2014. [DOI: 10.1200/jco.2014.32.15_suppl.6067] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | - Ismael Herruzo
- Hospital Regional Universitario Carlos Haya, Málaga, Spain
| | | | | | | | | | - Jesus Romero
- Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - Virginia Arrazubi
- Service of Medical Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Isabel Prieto
- Hospital Universitario Gregorio Marañon, Madrid, Spain
| | - Felipe A. Calvo
- Hospital General Universitario Gregorio Marañon, Madrid, Spain
| |
Collapse
|
43
|
Arias F, Arraras JI, Asin G, Uzcanga MI, Maraví E, Chicata V, Eito C, Zarandona U, Mora I, Vila M, Domínguez MA. Quality of life and voice assessment in patients with early-stage glottic cancer. Head Neck 2014; 37:340-6. [DOI: 10.1002/hed.23603] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2012] [Revised: 11/05/2013] [Accepted: 01/07/2014] [Indexed: 11/08/2022] Open
Affiliation(s)
- Fernando Arias
- Department of Radiation Oncology; Complejo Hospitalario de Navarra; Navarra Spain
| | - Juan Ignacio Arraras
- Department of Radiation Oncology; Complejo Hospitalario de Navarra; Navarra Spain
| | - Gemma Asin
- Department of Radiation Oncology; Complejo Hospitalario de Navarra; Navarra Spain
| | - María Itziar Uzcanga
- Department of Otorhinolaryngology; Complejo Hospitalario de Navarra; Navarra Spain
| | - Enrique Maraví
- Department of Otorhinolaryngology; Complejo Hospitalario de Navarra; Navarra Spain
| | - Volker Chicata
- Department of Radiation Oncology; Complejo Hospitalario de Navarra; Navarra Spain
| | - Clara Eito
- Department of Radiation Oncology; Complejo Hospitalario de Navarra; Navarra Spain
| | - Uxue Zarandona
- Department of Radiation Oncology; Complejo Hospitalario de Navarra; Navarra Spain
| | - Itxaso Mora
- Department of Radiation Oncology; Complejo Hospitalario de Navarra; Navarra Spain
| | - Meritxell Vila
- Department of Radiation Oncology; Complejo Hospitalario de Navarra; Navarra Spain
| | | |
Collapse
|
44
|
Arias F, Santos M, Fernández-Colino A, Pinedo G, Girotti A. Recent Contributions of Elastin-Like Recombinamers to Biomedicine and Nanotechnology. Curr Top Med Chem 2014; 14:819-36. [DOI: 10.2174/1568026614666140118223412] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2013] [Revised: 11/28/2013] [Accepted: 12/12/2013] [Indexed: 11/22/2022]
|
45
|
Errasti M, Rico M, Navarrete P, Barrado M, Campo M, Martínez E, Mañeru F, Villafranca E, Arias F, Dominguez M. EP-1181: SABR for lung lessons in patients previously treated with surgery. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31299-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
46
|
Villafranca E, Romero P, Arias F, Sola A, Eito C, Errasti M, de Miguel M, Armendariz P, Ciga M, Oteiza F. Intraoperative high dose rate brachytherapy (HDR-IORT) in locally advanced rectal cancer. Rep Pract Oncol Radiother 2013. [DOI: 10.1016/j.rpor.2013.03.664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
47
|
Rico M, Pellejero S, Martínez E, Martín M, Arias F, Eito C, Mañeru F, Errasti M, Barrado M, Villafranca E, Domínguez M. Stereotactic body radiation therapy for lung tumors: Analysis of margin requirements and treatment time. Rep Pract Oncol Radiother 2013. [DOI: 10.1016/j.rpor.2013.03.558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
48
|
Errasti M, Manterola A, Lozares S, Barrado M, Eito C, Asín G, Rico M, Dominguez M, Arias F, Sola A, Martínez E, Villafranca E. Active breathing control in left breast irradiation, our experience center. Rep Pract Oncol Radiother 2013. [DOI: 10.1016/j.rpor.2013.03.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
49
|
Maneru F, Fuentemilla N, Otal A, Olasolo J, Martin M, Lozares S, Pellejero S, Miquelez S, Soto P, Arias F, Rubio A. SU-E-T-626: Three-Beam Technique for Intensity Modulated Radiation Therapy in Oesophagus: Dosimetric Differences in Organs at Risk. Med Phys 2013. [DOI: 10.1118/1.4815054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
50
|
Rico M, Martínez E, Pellejero S, Arias F, Eito C, Mora I, Errasti M, Barrado M, Marín M, Mañeru F, Domínguez M. Stereotactic body radiation therapy for lung tumours: Initial experience of a centre. Rep Pract Oncol Radiother 2013. [DOI: 10.1016/j.rpor.2013.03.559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|